Transplantation, AutologousLymphoma, Large B-Cell, DiffuseHematopoietic Stem Cell TransplantationStem Cell TransplantationLymphoma, B-CellAntineoplastic Combined Chemotherapy ProtocolsPeripheral Blood Stem Cell TransplantationMultiple MyelomaMelphalanLymphoma, Non-HodgkinTreatment OutcomeTransplantation, HomologousTransplantation ConditioningVincristineAntibodies, Monoclonal, Murine-DerivedCombined Modality TherapyCyclophosphamideLymphoma, FollicularRemission InductionDoxorubicinProto-Oncogene Proteins c-bcl-6PrednisoneSalvage TherapyDisease-Free SurvivalHodgkin DiseaseStem CellsEtoposideGerminal CenterPrognosisRecurrenceCytarabineSurvival RateRetrospective StudiesMyeloablative AgonistsLymphomaSurvival AnalysisCarmustineHematopoietic Stem Cell MobilizationBone Marrow TransplantationGraft vs Host DiseaseThiotepaChemotherapy-Induced Febrile NeutropeniaBone Marrow PurgingHematologic NeoplasmsLymphoma, T-Cell, PeripheralLymphoma, Mantle-CellWhole-Body IrradiationFatal OutcomeAmyloidosisHematopoietic Stem CellsBoronic AcidsDexamethasonePyrazinesBusulfanB-LymphocytesLymphoproliferative DisordersAntineoplastic AgentsTranslocation, GeneticFollow-Up StudiesGraft SurvivalAntineoplastic Agents, AlkylatingEpstein-Barr Virus InfectionsLymphoma, B-Cell, Marginal ZoneCARD Signaling Adaptor ProteinsIfosfamideAntigens, CD34ThalidomideAutograftsLiver TransplantationTime FactorsInduction ChemotherapyGranulocyte Colony-Stimulating FactorMesenchymal Stem Cell TransplantationPodophyllotoxinLeukapheresisImmunohistochemistryNeoplasm, ResidualTransplantation ChimeraMaintenance ChemotherapyTissue DonorsLeukemia, Myeloid, AcuteCord Blood Stem Cell TransplantationAntibodies, MonoclonalCisplatinCell TransplantationDrug Administration ScheduleMitoxantroneKidney TransplantationCarboplatinMyelodysplastic SyndromesEnteropathy-Associated T-Cell LymphomaCell Line, TumorEmbryonic Stem CellsNeoplasms, Second PrimaryIdarubicinNeoplasm Recurrence, LocalTumor Markers, BiologicalProspective StudiesInfusions, SpinalLeukemia, Plasma Cell